Literature DB >> 33716970

Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?

Ping Liu1,2, Ban Luo3, Lang Chen1, Qiu-Xia Wang1, Gang Yuan4, Gui-Hua Jiang2, Jing Zhang1.   

Abstract

Objective: Prediction of therapy response to intravenous methylprednisolone pulses (ivMP) is crucial for thyroid-associated ophthalmopathy (TAO). Image histograms may offer sensitive imaging biomarkers for therapy effect prediction. This study aimed to investigate whether pretherapeutic, multiparametric T2 relaxation time(T2RT) histogram features of extraocular muscles (EOMs) can be used to predict therapy response. Materials and
Methods: Forty-five active and moderate-severe TAO patients, who were treated with standard ivMP and underwent orbital MRI before therapy, were retrospectively included in this study. The patients were divided into responsive (n = 24, 48 eyes) and unresponsive group(n = 21, 42 eyes) according to clinical evaluation. Baseline clinical features of patients and histogram-derived T2RT parameters of the EOMs were analyzed and compared. Logistic regression model was conducted to determine independent predictors, and a histogram features nomogram was formulated for personalized prediction.
Results: Responsive group displayed lower values for 5th, 10th percentiles (P < 0.050, respectively), and higher values for 75th, 90th, and 95th percentiles, skewness, entropy, and inhomogeneity (P < 0.050, respectively) than unresponsive group. Multivariate logistic regression analysis showed that 95th percentile of >88.1 [odds ratio (OR) = 12.078; 95% confidence interval (CI) = 3.98-36.655, p < 0.001], skewness of >0.31 (OR = 3.935; 95% CI = 2.28-6.788, p < 0.001) and entropy of >3.41 (OR = 4.375; 95% CI = 2.604-7.351, p < 0.001) were independent predictors for favorable response. The nomogram integration of three independent predictors demonstrated optimal predictive efficiency, with a C-index of 0.792. Conclusions: Pre-treatment volumetric T2RT histogram features of EOMs could function to predict the response to ivMP in patients with TAO. The nomogram based on histogram features facilitates the selection of patients who will derive maximal benefit from ivMP.
Copyright © 2021 Liu, Luo, Chen, Wang, Yuan, Jiang and Zhang.

Entities:  

Keywords:  T2 relaxation time; extraocular muscle; intravenous methylprednisolone pulse; thyroid associated ophthalmopathy; treatment response

Mesh:

Substances:

Year:  2021        PMID: 33716970      PMCID: PMC7947366          DOI: 10.3389/fendo.2021.614536

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  37 in total

1.  Graves ophthalmopathy: role of MR imaging in radiation therapy.

Authors:  M Just; G Kahaly; H P Higer; H P Rösler; J Kutzner; J Beyer; M Thelen
Journal:  Radiology       Date:  1991-04       Impact factor: 11.105

2.  Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas.

Authors:  Hye Jin Baek; Ho Sung Kim; Namkug Kim; Young Jun Choi; Young Joong Kim
Journal:  Radiology       Date:  2012-07-06       Impact factor: 11.105

Review 3.  Graves' Disease.

Authors:  Terry J Smith; Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2016-10-20       Impact factor: 91.245

4.  Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.

Authors:  Kai Hou; Tao Ai; Wei-Kun Hu; Ban Luo; Yi-Ping Wu; Rong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

5.  Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods.

Authors:  Wen Chen; Hao Hu; Huan-Huan Chen; Guo-Yi Su; Tao Yang; Xiao-Quan Xu; Fei-Yun Wu
Journal:  Acta Radiol       Date:  2020-02-13       Impact factor: 1.990

6.  Teprotumumab for Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; George J Kahaly; Daniel G Ezra; James C Fleming; Roger A Dailey; Rosa A Tang; Gerald J Harris; Alessandro Antonelli; Mario Salvi; Robert A Goldberg; James W Gigantelli; Steven M Couch; Erin M Shriver; Brent R Hayek; Eric M Hink; Richard M Woodward; Kathleen Gabriel; Guido Magni; Raymond S Douglas
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

7.  Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.

Authors:  Fabio Tortora; Mariaevelina Prudente; Mario Cirillo; Andrea Elefante; Maria Paola Belfiore; Francesco Romano; Salvatore Cappabianca; Carlo Carella; Sossio Cirillo
Journal:  Neuroradiology       Date:  2014-02-27       Impact factor: 2.804

Review 8.  Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.

Authors:  Wilmar M Wiersinga
Journal:  Lancet Diabetes Endocrinol       Date:  2016-06-23       Impact factor: 32.069

Review 9.  Improving tumour heterogeneity MRI assessment with histograms.

Authors:  N Just
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

10.  Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves' Ophthalmopathy.

Authors:  Lingling Xu; Linna Li; Cuihua Xie; Meiping Guan; Yaoming Xue
Journal:  Int J Endocrinol       Date:  2017-08-06       Impact factor: 3.257

View more
  2 in total

Review 1.  Extraocular muscle enlargement.

Authors:  Khizar Rana; Valerie Juniat; Sandy Patel; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-17       Impact factor: 3.535

2.  T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy.

Authors:  Linhan Zhai; Qiuxia Wang; Ping Liu; Ban Luo; Gang Yuan; Jing Zhang
Journal:  Korean J Radiol       Date:  2022-04-26       Impact factor: 7.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.